Publications by authors named "Timo Nykopp"

Claim this Profile
H
Healthcare Resource Use and Costs of Localized Prostate Cancer Patients in Finland.
Teemu J Murtola, Tuukka Hakkarainen, Mari Lahelma, Paula Pennanen, Riikka-Leena Leskelä, Timo K Nykopp

Clin Genitourin Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual Reality Learning in Suprapubic Catheter Insertion: The Role of Peer-Tutor Guidance Versus Teacher.
Henrik Nuutinen, Mari Lavikainen, Timo K Nykopp, Joonas Sirola

Clin Teach· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers.
Otto Jokelainen, Teemu Rintala, Satu Remes, Sanna Pasonen-Seppänen, Timo K Nykopp

J Pathol Clin Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The usage of the paris classification system in urine cytology in the diagnosis of non-muscle-invasive bladder cancer: a retrospective single-center study.
Perttu Saarinen, Otto Jokelainen, Liida Ruotsalainen, Essi Ikonen, Timo K Nykopp

Discov Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.
Otto Jokelainen, Teemu J Rintala, Vittorio Fortino, Sanna Pasonen-Seppänen, Reijo Sironen, Timo K Nykopp

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
Oona Janhunen, Otto Jokelainen, Robin Peltoniemi, Timo K Nykopp, Otso Arponen

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national precision cancer medicine implementation initiative for Finland.
Katriina J Jalkanen, Erika Alanne, Sanna Iivanainen, Okko-Sakari Kääriäinen, Minna Tanner, Timo K Nykopp

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guérin.
Geneviève Trépanier, Timo Nykopp, Raphaëlla Rosebush-Mercier, Typhaine Gris, Jonathan Fadel

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland.
Ilkka Nikulainen, Antti P Salminen, Heikki Seikkula, Mikael Högerman, Ileana Montoya Perez, Timo K Nykopp

Acta Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of teacher's presence on learning basic surgical tasks with virtual reality headset among medical students.
Sofianna Ojala, Joonas Sirola, Timo Nykopp, Heikki Kröger, Henrik Nuutinen

Med Educ Online· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group.
Gautier Marcq, Luca Afferi, Yann Neuzillet, Timo Nykopp, Charlotte S Voskuilen

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative complications in kidney tumor surgery: critical grading for the European Association of Urology intraoperative adverse incident classification.
Harry Nisen, Kaisa Erkkilä, Otto Ettala, Hanna Ronkainen, Taina Isotalo, Timo Nykopp

Scand J Urol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.
Jose Batista da Costa, Ewan A Gibb, Timo K Nykopp, Miles Mannas, Alexander W Wyatt

Urol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does every Clavien-Dindo complication matter? A national multi-center study in kidney cancer surgery.
Erkkilä Kaisa, Thea Veitonmäki, Otto Ettala, Hanna Ronkainen, Taina Isotalo, Timo Nykopp

Scand J Urol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular hyaluronan is associated with a poor prognosis in renal cell carcinoma.
Otto Jokelainen, Sanna Pasonen-Seppänen, Markku Tammi, Arto Mannermaa, Sirpa Aaltomaa, Timo K Nykopp

Urol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study.
Antti P Salminen, Ilmari Koskinen, Ileana Montoya Perez, Saija Hurme, Teemu J Murtola, Timo K Nykopp

Eur Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A risk-stratified approach to the management of high-grade T1 bladder cancer.
Miles P Mannas, Taeweon Lee, Timo K Nykopp, Jose Batista da Costa, Peter C Black

Curr Opin Urol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Clinical Trials in Non-muscle Invasive Bladder Cancer.
Timo K Nykopp, Jose Batista da Costa, Miles Mannas, Peter C Black

Curr Urol Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer.
Timo K Nykopp, Sanna Pasonen-Seppänen, Markku I Tammi, Raija H Tammi, Veli-Matti Kosma

Gynecol Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
Hanna Tuhkanen, Jaana M Hartikainen, Ylermi Soini, Gloria Velasco, Reijo Sironen, Timo K Nykopp

Int J Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival.
Jaana M Kauppinen, Veli-Matti Kosma, Ylermi Soini, Reijo Sironen, Minna Nissinen, Timo K Nykopp

Cancer Epidemiol Biomarkers Prev· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.
Timo K Nykopp, Kirsi Rilla, Markku I Tammi, Raija H Tammi, Reijo Sironen

BMC Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Division of the hepatic branch of the anterior vagus nerve in fundoplication: effects on gallbladder function.
Martin Purdy, Timo K Nykopp, Sakari Kainulainen, Matti Pääkkönen

Surg Endosc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
Timo K Nykopp, Kirsi Rilla, Reijo Sironen, Markku I Tammi, Raija H Tammi

BMC Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis